Ischemia-induced transplant arteriosclerosis in the rat: Induction of peptide growth factor expression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 12, 1996, Pages 1516-1523

  Waltenberger, Johannes ^a,b   Akyürek, M Levent ^c   Aurivillius, Magnus ^b   Wanders, Alkwin ^c   Larsson, Erik ^c   Fellström, Bengt ^c   Funa, Keiko ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

arteriosclerosis; growth factors; ischemia; neointima; transplantation

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030454222     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.12.1516     Document Type: Article

References (54)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Gibbons GH, Dzau VJ. Mechanisms of disease: the emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431-1438.
3. Nilsson J. Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis. 1986;62:185-199.
4. Libby P, Warner SJC, Salomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med. 1988;318:1493-1498.
5. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Maiden LT, Masuko H, Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 1990;248: 1009-1012.
6. Thompson WD, McGuigan CJ, Snyder C, Keen GA, Smith EB. Mitogenic activity in human atherosclerotic lesions. Atherosclerosis. 1987;66:85-93.
7. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 1990;87: 4600-4604.
8. Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury. Am J Pathol. 1992; 140:1017-1023.
9. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
10. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
11. Nabel EG, Shum L, Pompili VJ, Yang Z-Y, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90: 10759-10763.
12. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253: 1129-1132.
13. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
14. Wanders A, Akyürek ML, Waltenberger J, Stafberg C, Larsson E, Zhiping R, Funa K, Fellström B. Impact of ischemia time on chronic vascular rejection in the rat: effects of angiopeptin. Transplant Proc. 1993;25:2098-2099.
15. Wanders A, Akyürek ML, Waltenberger J, Zhiping R, Stafberg C, Funa K, Larsson E, Fellström B. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol. 1995;15:145-155.
16. Isik FF, McDonald TO, Ferguson M, Yamanaka E, Gordon D. Transplant arteriosclerosis in a rat aortic model. Am J Pathol. 1992;141: 1139-1149.
17. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Häyry P. Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscler Thromb. 1991;11:671-680.
18. Paul LC, Häyry P, Foegh M, Dennis MJ, Mihatsch MJ, Larsson E, Fellström B. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transplant Proc. 1993;25:2022-2023.
19. Gao S, Schroeder J, Alderman E, Hunt S, Silverman J, Wiederhold V, Stinson E. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation. 1987;76(pt 2):V-56-V-61.
20. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant. 1992;11:S38-S44.
21. Jacobsson J, Wahlberg J, Frödin L, Odlind B, Tufveson G. Organ flush out solutions and cold storage preservation solutions: effect on organ cooling and post ischemic erythrocyte trapping in kidney grafts. Scand J Urol Nephrol. 1989;32:219-224.
22. Waltenberger J, Lundin L, Öberg K, Wilander E, Miyazono K, Heldin C-H, Funa K. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol. 1993;142:71-78.
23. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engström U, Heldin C-H. Transforming growth factor-β1, -β2 and -β3 secreted by a human glioblastoma cell line: identification of small and different forms of large latent complexes. J Biol Chem. 1992;267:19482-19488.
24. Coughlin SR, Escobedo JA, Williams LT. Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science. 1989;243: 1191-1194.
25. Smits A, Funa K, Vassbotn FS, Beausang-Linder M, af Ekenstam F, Heldin C-H, Westermark B, Nistér M. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am J Pathol. 1992;140:639-648.
26. Newman I, Wikinson PC. Method for phenotyping polarized and locomotor human lymphocytes. J Immunol Methods. 1992;147:43-50.
27. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243:393-396.
28. Daynes RA, Dowell T, Aranco BA. Platelet-derived growth factor is a potent biologic response modifier of T-cells. J Exp Med. 1991; 174:1323-1333.
29. Waltenberger J, Wanders A, Fellström B, Miyazono K, Heldin C-H, Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol. 1993;151:1147-1157.
30. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359: 693-698.
31. Kulkarni AB, Huh C-G, Becker D, Geiser A, Light M, Flanders KC, Roberts AB, Sporn MB, Ward IM, Karlsson S. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770-774.
32. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. Protective effect of transforming growth factor-β1 on experimental autoimmune disease in mice. Proc Natl Acad Sci U S A. 1991;88:2918-2922.
33. Brandes ME, Allen JB, Ogawa Y, Wahl SM. Transforming growth factor-β1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest. 1991;87:1108-1116.
34. Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA. Immunoregulatory role of transforming growth factor-β (TGF-β) in development of killer cells: comparison of active and latent TGF-β1. J Exp Med. 1990;172:1777-1784.
35. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T-cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Atherosclerosis. 1986;6: 131-138.
36. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 1990;67: 651-659.
37. Mennander A, Paavonen T, Häyry P. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated. Arterioscler Thromb. 1993;13:1019-1025.
38. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
39. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Williams LT, Zetter BR. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature. 1994;367:474-476.
40. Smits A, Hermansson M, Nistér M, Karnushina I, Heldin C-H, Westermark B, Funa K. Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors. 1989;2:1-8.
41. Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin C-H. Platelet-derived growth factor is angiogenic in vivo. Growth Factors. 1992;7:261-266.
42. Fellström B, Dimény E, Larsson E, Klareskog G, Tufveson G, Rubin K. Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection. Transplant Proc. 1989;21: 3689-3691.
43. Higgy NA, Davidoff AW, Grothman GT, Hollenberg MD, Benediktsson H, Paul LC. Expression of platelet-derived growth factor receptor in rat heart allografts. J Heart Lung Transplant. 1991;10: 1012-1022.
44. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 1992;89:465-473.
45. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106-113.
46. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest. 1991;88:904-911.
47. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990; 63:515-524.
48. Paulsson Y, Beckmann MP, Westermark B, Heldin C-H. Density-dependent inhibition of cell growth by transforming growth factor-β1 in normal human fibroblasts. Growth Factors. 1988; 1:19-27.
49. Björkerud S. Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb. 1991;11: 892-902.
50. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, Deuel TF. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109:429-440.
51. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
52. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature. 1994;370:460-462.
53. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med. 1995; 1:74-79.
54. Flaumenhaft R, Rifkin DB. The extracellular regulation of growth factor action. Mol Biol Cell. 1992;3:1057-1065.